Atopic Dermatitis Epidemiology Forecast Report 2030 | Epidemiological analysis of atopic dermatitis 2030 | SearchInsight
“DelveInsight LLP Commercial Research”
DelveInsight’s report “Atopic Dermatitis (AD) – Epidemiological Forecast to 2030” provides an in-depth understanding of the historical and predicted atopic dermatitis (AD) epidemiology within 7 MM, i.e. United States, EU5 (Germany, Spain, Italy), France and United Kingdom) and Japan.
DelveInsight has launched a new report on epidemiological predictions of atopic dermatitis, 2030.
Atopic dermatitis (eczema) is a condition that makes your skin red and itchy. It is common in children but can occur at any age. Atopic dermatitis is long lasting (chronic) and tends to worsen periodically. It can be accompanied by asthma or hay fever.
DelveInsight’s “Atopic Dermatitis Epidemiology Forecast to 2030” report provides an in-depth understanding of the disease, historical and predicted epidemiology of atopic dermatitis in the 7MM, i.e. US, EU5 (Germany, Spain, Italy, France and United Kingdom) and Japan.
Some of the highlights from the Atopic Dermatitis Epidemiology report:
The total prevalent AD population in the United States was estimated to be 32,197,083 in 2020, including 13,313,991 cases in children and 18,883,091 cases in adults.
The total population diagnosed with prevalent AD in the United States was 25,091,967 in 2020.
The prevalent AD population in the United States is expected to increase at a CAGR of 0.55% during the forecast period 2021-2030.
In 2020, the total prevalence of AD in adults in the United States was 5,684,566 in men and 9,421,907 in women.
Visit for more information on the epidemiology of atopic dermatitis
Scope of the report on the epidemiology of atopic dermatitis:
The Atopic Dermatitis report covers a detailed overview explaining its causes, symptoms, classification, pathophysiology, diagnosis and modes of treatment.
Atopic Dermatitis Epidemiology Report and Model provides an overview of risk factors and global trends for atopic dermatitis in the top seven markets (7MM: US, France, Germany, Italy, Spain, UK Uni and Japan)
The report provides an overview of the historical and forecasted atopic dermatitis patient pool in seven major markets covering the US, EU5 (Germany, Spain, France, Italy, UK) and Japan
Report Helps Recognize Growth Opportunities in 7MM Regarding Patient Population
Report assesses risk and burden of disease and highlights unmet need for atopic dermatitis
Report Provides Segmentation Of Atopic Dermatitis Epidemiology
1. Key information
2. Executive summary of atopic dermatitis
3. Overview of the epidemiology of atopic dermatitis at a glance
4. Atopic Dermatitis: Background and Overview of the Disease
5. Epidemiology and patient population
6. Case reports
7. Country wise-epidemiology of atopic dermatitis
9. Features of DelveInsight
Atopic Dermatitis Market
DelveInsight’s report “Atopic Dermatitis-Market Insights, Epidemiology, and Market Forecast — 2030” provides an in-depth understanding of 7MM, historical and predicted epidemiology as well as 7MM market trends in US, EU5 (Germany, France, Italy, Spain and United Kingdom),
Atopic dermatitis pipeline
DelveInsight’s “Atopic Dermatitis Pipeline Insight, 2021” report presents comprehensive information on current clinical development scenarios and growth prospects in the Atopic Dermatitis market. A detailed picture of the atopic dermatitis pipeline landscape is provided, which includes the disease overview and atopic dermatitis treatment guidelines.
Company Name: DelveInsight Business Research LLP
Contact: Kritika rehani
E-mail: Send an email
Address:304, boulevard S. Jones # 2432
City: Las Vegas
Country: United States